Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 11/2018

01-11-2018 | Brief Report

High Rate of Discontinuation May Diminish PrEP Coverage Among Young Men Who Have Sex with Men

Authors: Ethan Morgan, Daniel T. Ryan, Michael E. Newcomb, Brian Mustanski

Published in: AIDS and Behavior | Issue 11/2018

Login to get access

Abstract

Understanding pre-exposure prophylaxis (PrEP) discontinuation is key to maximizing its effectiveness at the individual and population levels. Data came from the RADAR cohort study of MSM aged 16–29 years, 2015–2017. Participants included those who reported past 6-month PrEP use and discontinued its use by the interview date. Of the 197 participants who had used PrEP in the past 6 months, 65 discontinued use. Primary reasons for PrEP discontinuation included trouble getting to doctor’s appointments (14, 21.5%) and issues related to insurance coverage or loss (13, 20.0%). Few (21%) who discontinued spoke to their doctor first, which has important implications for future long acting formulations.
Literature
1.
Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587–99.CrossRef
2.
Celum C, Baeten J. Tenofovir-based pre-exposure prophylaxis for HIV prevention: evidence and evolving questions. Curr Opin Infect Dis. 2012;25(1):51–7.CrossRef
3.
Van der Elst E, Mboqua J, Operario D, et al. High acceptability of HIV pre-exposure prophylaxis but challenges in adherence and use: qualitative insights from a phase I trial of intermittent and daily PrEP in at-risk populations in Kenya. AIDS Behav. 2013;17(6):2162–72.CrossRef
4.
Marcus JL, Hurley LB, Hare CB, et al. Preexposure prophylaxis for HIV prevention in a large integrated health care system: adherence, renal safety, and discontinuation. J Acquir Immune Defic Syndr. 2016;73(5):540–6.CrossRef
5.
Gerend M, Newcomb M, Mustanski BS. Prevalence and correlates of smoking and e-cigarette use among young men who have sex with men and transgender women. Drug Alcohol Depend. 2017;179:395–9.CrossRef
6.
Mustanski BS, Swann G, Newcomb M, Prachand NG. Effects of parental monitoring and knowledge on substance use and HIV risk behaviors among young men who have sex with men: results from three studies. AIDS Behav. 2017;21(7):2046–58.CrossRef
7.
CDC. HIV surveillance report, 2016. CDC; 2017.
8.
Molina J-M, Capitant C, Spire B, et al. On demand PrEP with oral TDF-FTC in MSM: results of the ANRS Ipergay Trial. In: Conference on retroviruses and opportunistic infections (CROI), 2015; Seattle, WA, 2015.
9.
Parsons JT, Rendina HJ, Grov C, Ventuneac A, Mustanski BS. Accuracy of highly sexually active gay and bisexual men’s predictions of their daily likelihood of anal sex and its relevance for intermittent event-driven HIV pre-exposure prophylaxis. J Acquir Immune Defic Syndr. 2015;68(4):449–55.CrossRef
10.
Murray M, Markowitz M, Frank I, et al. Tolerability and acceptability of Cabotegravir LA injection: results from ECLAIR study. In: Conference on retroviruses and opportunistic infections (CROI), 2016, Boston, MA, 2016.
Metadata
Title
High Rate of Discontinuation May Diminish PrEP Coverage Among Young Men Who Have Sex with Men
Authors
Ethan Morgan
Daniel T. Ryan
Michael E. Newcomb
Brian Mustanski
Publication date
01-11-2018
Publisher
Springer US
Published in
AIDS and Behavior / Issue 11/2018
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-018-2125-2

Other articles of this Issue 11/2018

AIDS and Behavior 11/2018 Go to the issue

Original Paper

“It Was Not My Aim to Sleep There”: The Impact of Timing and Location of Sex on Adherence to Coitally-Dependent HIV Pre-exposure Prophylaxis

Original Paper

Community Savings Groups, Financial Security, and HIV Risk Among Female Sex Workers in Iringa, Tanzania

Original Paper

Structural Effects on HIV Risk Among Youth: A Multi-level Analysis

Original Paper

Perceptions of Value and Cost of HIV Care Engagement Following Diagnosis in South Africa

Original Paper

Trends in Awareness and Use of HIV PrEP Among Gay, Bisexual, and Other Men who have Sex with Men in Vancouver, Canada 2012–2016

Original Paper

An Information–Motivation–Behavioral Skills Model of PrEP Uptake

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits